Oculis Holding AG Ordinary shares
Price & Volume
Stats
See more52W Range | $10.50-$34.47 |
Market Cap | $586.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $1.1M |
Revenue Growth (YoY) | 18.8% |
Gross Profit (12 Mos) | -$55.5M |
Diluted EPS | -$1.70 |
News
See moreYahoo Finance • last month
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
Yahoo Finance • last month
Oculis undirritar kaupsamning við Accure Therapeutics um leiðandi þróunarlyfið Privosegtor og eflir þannig stöðu Oculis sem leiðandi vaxtarfyrirtækis á sviði taugaaugnlækninga
Yahoo Finance • last month
Oculis Reports Q2 2026 Financial Results and Provides Company Update
Yahoo Finance • last month
Oculis birtir uppgjör fyrir annan ársfjórðung 2026 og kynnir áfanga í rekstri félagsins
About
CEO | Dr. Riad Sherif M.B.A., M.D. |
Address | Bahnhofstrasse 20, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 60 |